WQ92683 (e) Wedi’i gyflwyno ar 30/04/2024

A wnaiff yr Ysgrifennydd Cabinet amlinellu pa gymorth sydd ar gael i gleifion ag AMD Gwlyb, yn benodol o ran defnyddio pigiadau Avastin ar gyfer y rhai y mae eu golwg yn well na golwg 6/12?

Wedi'i ateb gan Ysgrifennydd y Cabinet dros Iechyd a Gofal Cymdeithasol | Wedi'i ateb ar 03/05/2024

In England commissioning bodies will only allow the use of Lucentis / eylea / faricimab etc in patients with vision worse than 6/12. In Wales this restriction doesn't apply, as we provide treatment to patients with a licensed medication based on their clinical need including those with eyesight better than 6/12.

Avastin is unlicensed for use in the eye. It is considerably cheaper than the specialist injections but not as effective and requires more frequent injections. It is used in England as commissioning bodies allow its use in patients with vision better than 6/12 on cost reasons. 

This would only apply to patients in Powys who receive injections across the border in England and we have no control over their treatment.